INHIBITION OF PLATELET AGGREGATION USING ANTI-HUMAN GPVI ANTIBODIES

摘要

the present invention relates to an isolated humanized protein that binds to glycoprotein vi (hgpvi) for the treatment of a condition related to gpvi in an individual in need thereof, wherein said isolated humanized protein is to be administered for at least 2 hours for the individual, preferably for at least 4 to 6 hours.